Amneal Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
130.85N/A
Price/Sales ratio
0.490.47
Earnings per Share (EPS)
$0.07N/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
N/A47.697.3311.40-10.14-1.059.8235.36-1.17-12.72-1.63-10.14
Price/Sales ratio
N/A9.321.491.851.030.390.330.340.130.440.090.39
Price/Book Value ratio
N/A-41.41-8.21-4.951.921.831.951.941.6354.040.711.83
Price/Cash Flow ratio
N/A77.0513.228.166.88373.401.772.944.613.093.25373.40
Price/Free Cash Flow ratio
N/A-646.68-159.4215.9411.24-6.652.153.77-11.783.86-8.31-6.65
Price/Earnings Growth ratio
N/AN/A0.07-0.580.05-0.00-0.08-0.500.000.170.000.00
Dividend Yield
N/A3.19%13.18%19.62%10.62%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
57.23%57.62%58.67%50.90%43.07%21.70%31.53%36.72%35.47%34.28%35.47%21.70%
Operating Profit Margin
28.37%26.23%27.97%23.71%-1.18%-8.44%4.57%9.99%9.33%8.53%8.53%-1.18%
Pretax Profit Margin
22.82%20.26%21.09%16.57%-12.19%-13.54%-1.79%1.49%-11.21%-1.68%-11.21%-12.19%
Net Profit Margin
22.52%19.56%20.36%16.21%-10.20%-37.11%3.44%0.96%-11.51%-3.50%-5.87%-10.20%
Effective Tax Rate
0.84%2.81%2.51%1.16%0.70%-174.04%291.66%35.69%-2.68%-20.98%-2.68%-174.04%
Return on Assets
N/A16.70%17.01%12.49%-3.89%-16.46%1.71%0.51%-6.70%-2.41%-3.42%-3.89%
Return On Equity
N/A-86.83%-111.92%-43.46%-18.93%-174.04%19.88%5.49%-138.48%-424.61%-41.02%-174.04%
Return on Capital Employed
N/A29.32%28.66%23.45%-0.51%-4.41%2.73%6.41%6.77%7.78%6.20%-0.51%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A2.322.192.29N/AN/AN/A1.872.19
Quick Ratio
N/A1.542.041.641.491.501.561.521.170.941.091.50
Cash ratio
N/A0.250.120.240.380.270.500.360.030.100.030.27
Days of Sales Outstanding
N/A115.37141.51124.07124.07142.71123.50115.51122.3893.58131.47124.07
Days of Inventory outstanding
N/A233.65230.88204.29176.30109.22131.28134.84135.69134.90135.69135.69
Operating Cycle
N/A349.02372.40328.36300.38251.93254.78250.35258.08228.48168.11251.93
Days of Payables Outstanding
N/A69.5352.0750.3544.2829.5241.2436.6042.6533.3142.4342.43
Cash Conversion Cycle
N/A279.48320.32278.00256.09222.40213.54213.74215.42195.17122.50222.40
Debt Ratios
Debt Ratio
N/A0.990.981.070.600.710.700.690.710.760.950.60
Debt Equity Ratio
N/A-5.18-6.45-3.742.957.588.167.4914.79133.4912.112.95
Long-term Debt to Capitalization
N/A1.251.191.390.740.880.880.880.930.990.900.74
Total Debt to Capitalization
N/A1.231.181.360.740.880.890.880.930.990.900.74
Interest Coverage Ratio
N/AN/AN/AN/A1.64-1.100.74N/AN/AN/A1.19-1.10
Cash Flow to Debt Ratio
N/A0.100.090.160.090.000.130.080.020.130.020.00
Company Equity Multiplier
N/A-5.19-6.57-3.474.8510.5711.6110.7320.65175.5512.734.85
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.140.120.110.220.150.000.190.110.020.140.020.00
Free Cash Flow / Operating Cash Flow Ratio
0.29-0.11-0.080.510.61-56.140.820.78-0.390.79-0.39-56.14
Cash Flow Coverage Ratio
N/A0.100.090.160.090.000.130.080.020.130.020.00
Short Term Coverage Ratio
N/A1.753.112.6211.660.078.377.890.721.620.620.07
Dividend Payout Ratio
137.34%152.35%96.73%223.84%-107.81%N/AN/AN/AN/AN/AN/A-107.81%